ISRG Financial Statements & Analysis
Complete financial statements for ISRG including income statement, balance sheet, and cash flow statement. Analyze ISRG's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
44
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
17.2% ↑
Net Income
29.2% ↑
Gross Margin
1.6% ↑
Operating Margin
13.4% ↑
Balance Sheet
Current Ratio
-14.3% ↓
Debt to Equity
100.0% ↓
Asset Turnover
-3.9% ↓
Cash Flow
Operating Cash Flow
33.1% ↑
Net Cash Flow
-160.5% ↓
Free Cash Flow
73.9% ↑
Cash Flow to Debt
-100.0% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 7.12B | 8.35B | 17.2% | |
| Gross Profit | 4.73B | 5.63B | 19.1% | |
| Operating Income | 1.77B | 2.35B | 32.9% | |
| Net Income | 1.80B | 2.32B | 29.2% | |
| EPS | 5.12 | 6.5388 | 27.7% | |
| EBITDA | 2.17B | 2.81B | 29.6% | |
| Gross Margin | 66.39% | 67.46% | 1.6% | |
| Operating Margin | 24.80% | 28.12% | 13.4% | |
| Net Income Margin | 25.24% | 27.81% | 10.2% | |
| R&D Expenses | 998.80M | 1.15B | 14.7% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B |
| Gross Profit | 5.63B | 4.73B | 4.20B | 3.96B | 2.86B |
| Operating Income | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B |
| Net Income | 2.32B | 1.80B | 1.32B | 1.70B | 1.06B |
| EPS | 6.5388 | 5.12 | 3.72 | 4.79 | 3.02 |
| EBITDA | 2.81B | 2.17B | 1.94B | 2.13B | 1.33B |
| Gross Margin | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% |
| Operating Margin | 28.12% | 24.80% | 25.35% | 31.89% | 24.09% |
| Net Income Margin | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% |
| R&D Expenses | 1.15B | 998.80M | 879.00M | 671.00M | 595.10M |